Literature DB >> 13722011

Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli.

B M DERBY, D E ROGERS.   

Abstract

Observations are presented on the course of experimental bacteriemia in rabbits modified by thorotrast reticuloendothelial "blockade" and mechlorethamine induced leukopenia, given singly and together. The production of severe granulocytopenia did not impair the clearance of staphylococci from the blood stream and did not enhance the impairment of clearance produced by thorotrast reticuloendothelial "blockade." Neither severe granulocytopenia nor thorotrast blockade alone produced consistent impairment in the removal of circulating E. coli from the blood stream, whereas when these conditions were present together, the early phases of clearance in these animals were virtually prevented. These results indicate that the host mechanisms operative in the control of bacteriemia differ for staphylococci and E. coli. It is suggested that the fate of bacteria within polymorphonuclear leukocytes may in part determine the importance of these cells in the removal of bacteria from the blood stream.

Entities:  

Keywords:  ESCHERICHIA COLI INFECTIONS/experimental; LEUKOPENIA/experimental; RETICULOENDOTHELIAL SYSTEM; SEPTICEMIA/experimental; STAPHYLOCOCCAL INFECTIONS/experimental

Mesh:

Year:  1961        PMID: 13722011      PMCID: PMC2137435          DOI: 10.1084/jem.113.6.1053

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  A comparative survey of the phagocytosis of different species of bacteria by Kupffer cells; perfusion studies with the isolated rat liver.

Authors:  A C WARDLAW; J G HOWARD
Journal:  Br J Exp Pathol       Date:  1959-04

2.  Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci.

Authors:  D E ROGERS
Journal:  J Exp Med       Date:  1956-06-01       Impact factor: 14.307

3.  The effect of thorotrast on the removal of bacteria in the splanchnic area of the intact animal.

Authors:  S P MARTIN; G P KERBY; B C HOLLAND
Journal:  J Immunol       Date:  1952-03       Impact factor: 5.422

4.  On the nature of bacteremia in experimental pneumococcal pneumonia in the dog. II. Disappearance of pneumococci from the circulation in relation to the bactericidal action of the blood in vitro.

Authors:  L A GREGG; O H ROBERTSON
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

5.  Acute infection of mice with Smith strain of Staphylococcus aureus.

Authors:  G A HUNT; A J MOSES
Journal:  Science       Date:  1958-12-19       Impact factor: 47.728

6.  Further observations on the behavior of staphylococci within human leukocytes.

Authors:  D E ROGERS; M A MELLY
Journal:  J Exp Med       Date:  1960-04-01       Impact factor: 14.307

7.  Studies on the cellular immunology of acute bacteremia. I. Intravascular leucocytic reaction and surface phagocytosis.

Authors:  W B WOOD; M R SMITH; W D PERRY; J W BERRY
Journal:  J Exp Med       Date:  1951-12-01       Impact factor: 14.307

8.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

9.  Studies on bacteriemia. II. Further observations on the granulocytopenia induced by the intravenous injection of Staphylococci.

Authors:  D E ROGERS; M A MELLY
Journal:  J Exp Med       Date:  1957-02-01       Impact factor: 14.307

10.  Studies on bacteriemia. III. The blood stream clearance of Escherichia coli in rabbits.

Authors:  D E ROGERS; M A MELLY
Journal:  J Exp Med       Date:  1957-02-01       Impact factor: 14.307

View more
  11 in total

1.  STUDIES ON EXPERIMENTAL BACTEREMIA AND RETICULOENDOTHELIAL FUNCTION.

Authors:  D E ROGERS; M G KOENIG; M A MELLY; R M HEYSSEL
Journal:  Trans Am Clin Climatol Assoc       Date:  1964

2.  Intravenous IgG: A New Therapeutic Tool.

Authors:  L K Boshkov; J G Kelton
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

3.  Intravenous immune globulin impairs anti-bacterial defences of a cyclophosphamide-treated host.

Authors:  A S Cross; G Siegel; W R Byrne; M Trautmann; D S Finbloom
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Effects of RES "blockade" on antibody-formation. I. Suppressed cellular and humoral haemolysin responses in mice injected with carbon particles.

Authors:  T Sabet; C Newlin; H Friedman
Journal:  Immunology       Date:  1969-04       Impact factor: 7.397

Review 5.  Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Authors:  Guy E Thwaites; Vanya Gant
Journal:  Nat Rev Microbiol       Date:  2011-02-07       Impact factor: 60.633

6.  THE DYNAMICS OF RETICULOENDOTHELIAL BLOCKADE.

Authors:  M G KOENIG; R M HEYSSEL; M A MELLY; D E ROGERS
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

7.  Experimental production of lethal Escherichia coli bacteremia of pelvic origin.

Authors:  A I Braude; H Douglas; J Jones
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

8.  Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model.

Authors:  D P Greenberg; A S Bayer; A L Cheung; J I Ward
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors:  M G KOENIG
Journal:  Yale J Biol Med       Date:  1962-06

10.  Manipulation of Autophagy in Phagocytes Facilitates Staphylococcus aureus Bloodstream Infection.

Authors:  Kate M O'Keeffe; Mieszko M Wilk; John M Leech; Alison G Murphy; Maisem Laabei; Ian R Monk; Ruth C Massey; Jodi A Lindsay; Timothy J Foster; Joan A Geoghegan; Rachel M McLoughlin
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.